Immunoanalysis indicates that the sodium iodide symporter is not overexpressed in intracellular compartments in thyroid and breast cancers

European Journal of Endocrinology

Volumn 160, Issue 2, 2009, Pages 215-225

  Peyrottes, Isabelle ^a   Navarro, Valerie ^b   Ondo Mendez, Alejandro ^b,c   Marcellin, Didier ^d   Bellanger, Laurent ^d   Marsault, Robert ^b   Lindenthal, Sabine ^b   Ettore, Francette ^a   Darcourt, Jacques ^b   Pourcher, Thierry ^b  

^a CENTRE ANTOINE LACASSAGNE   (France)

^b Laboratoire TIRO   (France)

^c University of Colombia   (Colombia)

^d DIF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SODIUM IODIDE SYMPORTER; COTRANSPORTER; IODIDE; MONOCLONAL ANTIBODY; PARAFFIN;

ANTIGEN BINDING; ARTICLE; BREAST CANCER; CANCER SCREENING; CELL LABELING; CELL LEVEL; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; THYROID CANCER; WESTERN BLOTTING; ADENOCARCINOMA; ADENOMA; ANIMAL; BREAST TUMOR; GRAVES DISEASE; HASHIMOTO DISEASE; IMMUNOLOGY; LIVER CELL; MEDULLARY CARCINOMA; METABOLISM; MOUSE; PAPILLARY CARCINOMA; PATHOLOGY; THYROID TUMOR;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; ANIMALS; ANTIBODIES, MONOCLONAL; BREAST NEOPLASMS; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; CELL MEMBRANE; GRAVES DISEASE; HASHIMOTO DISEASE; HEPATOCYTES; HUMANS; IMMUNOHISTOCHEMISTRY; IODIDES; MICE; PARAFFIN EMBEDDING; SYMPORTERS; THYROID NEOPLASMS;

EID: 61449152025     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0505     Document Type: Article

References (43)

1. Dai G, Levy O & Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996 379 458-460.
2. Smanik PA, Liu Q, Furminger TL, Ryu K, Xing S, Mazzaferri EL & Jhiang SM. Cloning of the human sodium lodide symporter. Biochemical and Biophysical Research Communications 1996 226 339-345.
3. Perron B, Rodriguez AM, Leblanc G & Pourcher T. Cloning of the mouse sodium iodide symporter (mNIS) and its expression in the mammary gland and other tissues.. Journal of Endocrinology 2001 170 185-196.
4. Dohan O, De La Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS & Carrasco N. The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 2003 24 48-77.
5. - symporter (NIS). Implications for its secondary structure model. Journal of Biological Chemistry 1998 273 22657-22663.
6. Smanik PA, Ryu KY, Theil KS, Mazzaferri EL & Jhiang SM. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997 138 35553-558.
7. Arturi F, Russo D, Schlumberger M, Du Villard JA, Caillou B, Vigneri P, Wicker R, Chiefari E, Suarez HG & Filetti S. Iodide symporter gene expression in human thyroid tumors. Journal of Clinical Endocrinology and Metabolism 1998 83 2493-2496.
8. Ryu KY, Senokozlieff ME, Smanik PA, Wong MG, Siperstein AE, Duh QY, Clark OH, Mazzaferri EL & Jhiang SM. Development of reverse transcription-competitive polymerase chain reaction method to quantitate the expression levels of human sodium iodide symporter (in process citation). Thyroid 1999 9 405-409.
9. - symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. Journal of Clinical Endocrinology and Metabolism 1999 84 3228-3234.
10. Park HJ, Kim JY, Park KY, Gong G, Hong SJ & Ahn IM. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid 2000 10 211-217.
11. Liou MJ, Lin JD, Chan EC, Liu FH, Chao TC & Weng HF. Detection of mRNA of sodium iodide symporter in benign and malignant human thyroid tissues. Cancer Letters 2000 160 75-80.
12. Arturi F, Russo D, Bidart JM, Scarpelli D, Schlumberger M & Filetti S. Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. European Journal of Endocrinology 2001 145 129-135.
13. Ringel MD, Anderson J, Souza SL, Burch HB, Tambascia M, Shriver CD & Tuttle RM. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Modern Pathology 2001 14 289-296.
14. Trouttet-Masson S, Selmi-Ruby S, Bernier-Valentin F, Porra V, Berger-Dutrieux N, Decaussin M, Peix JL, Perrin A, Bournaud C, Orgiazzi J, Borson-Chazot F, Franc B & Rousset B. Evidence for transcriptional and posttranscriptional alterations of the sodium/iodide symporter expression in hypofunctioning benign and malignant thyroid tumors. American Journal of Pathology 2004 165 25-34.
15. - symporter in human thyroid tissues and salivary gland tissues. Endocrinology 1998 139 4416-4419.
16. - symporter distribution in human thyroid tissues: an immunohistochemical study. Journal of Clinical Endocrinology and Metabolism 1998 83 4102-4106.
17. Castro MR, Bergert ER, Beito TG, Mciver B, Goellner JR & Morris JC. Development of monoclonal antibodies against the human sodium iodide symporter: immunohistochemical characterization of this protein in thyroid cells. Journal of Clinical Endocrinology and Metabolism 1999 84 2957-2962.
18. -) symporter (NIS) in a large sampling of thyroid cancer cases. Journal of Clinical Endocrinology and Metabolism 2001 86 2697-2700.
19. Wapnir IL, Van De Rijn M, Nowels K, Amenta PS, Walton K, Montgomery K, Greco RS, Dohan O & Carrasco N. Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. Journal of Clinical Endocrinology and Metabolism 2003 88 1880-1888.
20. Tonacchera M, Viacava P, Agretti P, De Marco G, Perri A, Di Cosmo C, De Servi M, Miccoli P, Lippi F, Naccarato AG, Pinchera A, Chiovato L & Vitti P. Benign nonfunctioning thyroid adenomas are characterized by a defective targeting to cell membrane or a reduced expression of the sodiumiodide symporter protein. Journal of Clinical Endocrinology and Metabolism 2002 87 352-357.
21. Riesco-Eizaguirre G & Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. European Journal of Endocrinology 2006 155 495-512.
22. Tazebay UH, Wapnir IL, Levy O, Dohan O, Zuckier LS, Hua Zhao Q, Fu Deng H, Amenta PS, Fineberg S, Pestell RG & Carrasco N. The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nature Medicine 2000 6 871-878.
23. - symporter expression in mammary glands. Journal of Clinical Endocrinology and Metabolism 2000 85 2936-2943.
24. Ronga G, Bruno R, Puxeddu E, Calcinaro F, Montesano T, Travascio L, Colandrea M, Durante C, Maranghi M, Filetti S & Russo D. Radioiodine uptake in non-lactating mammary glands: evidence for a causative role of hyperprolactinemia. Thyroid 2007 17 363-366.
25. Hedinger C, Williams ED & Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer 1989 63 908-911.
26. De Stgroth SF & Scheidegger D. Production of monoclonal antibodies: strategy and tactics. Journal of Immunological Methods 1980 35 1-21.
27. Dayem M, Navarro V, Marsault R, Darcourt J, Lindenthal S & Pourcher T. From the molecular characterization of iodide transporters to the prevention of radioactive iodide exposure. Biochimie 2006 88 1793-1806.
28. Pohlenz J, Duprez L, Weiss RE, Vassart G, Refetoff S & Costagliola S. Failure of membrane targeting causes the functional defect of two mutant sodium iodide symporters (see comments). Journal of Clinical Endocrinology and Metabolism 2000 85 2366-2369.
29. Scipioni A, Ferretti E, Soda G, Tosi E, Bruno R, Costante G, Meringolo D, Arturi F, Durante C, Amorosi A, Foschini MP, Nardi F, Russo D & Filetti S. hNIS protein in thyroid: the iodine supply influences its expression and localization. Thyroid 2007 17 613-618.
30. - symporter with an anti-COOH terminus antibody. PNAS 1997 94 5568-5573.
31. Paire A, Bernier-Valentin F, Selmi-Ruby S & Rousset B. Characterization of the rat thyroid iodide transporter using anti- peptide antibodies. Relationship between its expression and activity. Journal of Biological Chemistry 1997 272 18245-18249.
32. Elston CW & Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience froma large study with long-term follow-up. Histopathology 1991 19 403-410.
33. Zeng Q, Chen G, Vlantis A, Tse G & Van Hasselt C. The contributions of oestrogen receptor isoforms to the development of papillary and anaplastic thyroid carcinomas. Journal of Pathology 2008 214 425-433.
34. Riedel C, Levy O & Carrasco N. Post-transcriptional regulation of the sodium/iodide symporter (NIS) by thyrotropin. Journal of Biological Chemistry 2001 276 21458-21463.
35. - symporter. Journal of Clinical Endocrinology and Metabolism 2005 90 6131-6140.
36. Dayem M, Basquin C, Navarro V, Carrier P, Marsault R, Chang P, Huc S, Darrouzet E, Lindenthal S & Pourcher T. Comparison of expressed human and mouse sodium/iodide symporters reveals differences in transport properties and subcellular localization. Journal of Endocrinology 2008 197 95-109.
37. Beyer SJ, Jimenez RE, Shapiro CL, Cho JY & Jhiang SM. Do cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer? Breast Cancer Research and Treatment, 2008 DOI: 10.1007/S10549-008-0059-5.
38. Berger F, Unterholzner S, Diebold J, Knesewitsch P, Hahn K & Spitzweg C. Mammary radioiodine accumulation due to functional sodium iodide symporter expression in a benign fibroadenoma. Biochemical and Biophysical Research Communications 2006 349 1258-1263.
39. Moon DH, Lee SJ, Park KY, Park KK, Ahn SH, Pai MS, Chang H, Lee HK & Ahn IM. Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nuclear Medicine and Biology 2001 28 829-834.
40. Upadhyay G, Singh R, Agarwal G, Mishra SK, Pal L, Pradhan PK, Das BK & Godbole MM. Functional expression of sodium iodide symporter (NIS) in human breast cancer tissue. Breast Cancer Research and Treatment 2003 77 157-165.
41. Thorpe SM. Increased uptake of iodide by hormone-responsive compared to hormone- independent mammary tumors in GR mice. International Journal of Cancer 1976 18 345-350.
42. Buchmann I, Riedmuller K, Hoffner S, Mack U, Aulmann S & Haberkorn U. Comparison of (99m)technetium-pertechnetate and (123)iodide SPECT with FDG-PET in patients suspicious for breast cancer. Cancer Biotherapy & Radiopharmaceuticals 2007 22 779-789.
43. Kogai T, Taki K & Brent GA. Enhancement of sodium/iodide symporter expression in thyroid and breast cancer. Endocrine-Related Cancer 2006 13 797-826.